PETER WIRTH
CIK 1021041 · Exec VP,Legal & Corporate Dev. · last filed 2025-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.79M
Companies
5
Total Filings
33
Lifetime Open-Market Net
-$17.89M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZLAB | Director | 397,750 | $17.07 | $6.79M | $293.3K | 8 | 2025-06-23 |
| SYRS | Director | 16,000 | $0.00 | $6 | $0 | 9 | 2024-06-07 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Director | 0 | $20.01 | $0 | $0 | 5 | 2022-10-14 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | Director | — | — | — | $0 | 3 | 2015-06-23 |
| GENZYME CORP (GENZ) Delisted | Exec VP,Legal & Corporate Dev. | 0 | — | — | -$18.18M | 8 | 2011-04-06 |
Recent Filings · Page 4 of 4
33 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-01-20 | GENZYME CORP (GENZ) Delisted | Mixed | — | -$8.60M | EDGAR |
| 2008-05-27 | GENZYME CORP (GENZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-05-29 | GENZYME CORP (GENZ) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–33 of 33
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.